Wegovy Shortage Resolved: 2026 Availability and Pill Launch

In the past several years, the Wegovy shortage made filling a prescription feel like a monthly scavenger hunt. Patients were busy calling multiple pharmacies, waiting for an order to arrive, and wondering whether they could continue their prescribed dose. The good news is that the national shortage of injectable semaglutide, including Wegovy, has been resolved.

And there's even more good news on the horizon in the form of a brand-new pill. Here's everything you need to know about what happened, what's changed, and how to make sure your treatment stays on track.

Is There a Shortage of Wegovy? Wegovy Shortage Update Today

On February 21, 2025, the U.S. Food and Drug Administration (FDA) updated its drug shortage database to mark the semaglutide injection shortage as resolved. That means Wegovy's manufacturer, Novo Nordisk, has confirmed that supply is now meeting or exceeding current and projected nationwide demand.

For the latest Wegovy supply update, the FDA's drug shortage tracker is your most reliable source. Is Wegovy still on backorder at your local pharmacy? Possibly, in isolated cases, but those shortages are now the result of normal inventory movement through the supply chain, not a nationwide manufacturing crisis. The days of Wegovy unavailable warnings on a national scale are behind us.

Wegovy Availability Over the Past Years

To understand where things stand today, it helps to look back. The Wegovy availability timeline has been a bit of a rollercoaster:

• 2021: The FDA approves Wegovy (semaglutide injection 2.4 mg) for chronic weight management in adults with obesity.
• March 2022: The shortage begins as prescriptions increase much faster than supply can keep up with.
• 2022 to 2024: Demand increases. Patients across the country struggle to find their doses, pharmacies field daily calls, and compounding pharmacies step in to fill the void.
• February 21, 2025: The FDA declares the semaglutide shortage resolved after Novo Nordisk expands manufacturing to 24/7 operations and builds significant finished-product reserves.
• December 2025: The FDA approves the oral Wegovy pill (semaglutide 25 mg tablet), the first oral GLP-1 medication approved for weight management.
• January 2026: The Wegovy pill launches in U.S. pharmacies, manufactured at Novo Nordisk's North Carolina facilities.

So, if you've been wondering, “When will Wegovy be back in stock?” The answer is that it's largely already there. Supply continues to improve, and the new oral option is adding even more flexibility.

Which Doses Were Affected?

Wegovy injections come in five strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. During the shortage, availability changed often. In some months, the lower starting doses, such as 0.25 mg and 0.5 mg, were harder to find because many people were starting treatment at the same time. In other months, higher maintenance doses were more limited.

This made the shortage difficult to predict. Supply depended on how many people were starting Wegovy, increasing their dose, or staying on a maintenance dose at any given time.

The new oral Wegovy pill follows a different dosing schedule. It is available in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths, with the dose gradually increasing until reaching the 25 mg maintenance dose.

Why Was Wegovy Not Available?

There are several reasons Wegovy was not available.

Explosive Demand Outpaced Supply

The main reason Wegovy was not available for so long comes down to one word: popularity. The number of people starting Wegovy has increased significantly, according to Novo Nordisk. Research showing that semaglutide can produce roughly 15% body weight loss drove unprecedented demand. Physicians became more comfortable prescribing it, patients requested it, and the media coverage was relentless.

Then the evidence expanded even further. Studies showed GLP-1 agonists like semaglutide could also reduce the risk of heart attacks and cardiovascular events in people with obesity, widening the eligible patient population further. More approved uses meant more prescriptions, and the supply simply couldn't keep pace.

Manufacturing Wegovy Is Genuinely Complex

This isn't a case where Novo Nordisk just needed to order more ingredients and crank up the machines. Wegovy is a peptide, a chain of amino acids, packaged into single-use injectable pens. Manufacturing peptides is expensive and highly technical. Unlike tablets, these pens require precision production lines that take significant time and capital investment to build. Novo Nordisk invested heavily in expanding manufacturing facilities and eventually shifted to round-the-clock production to close the gap.

Compounders Complicated the Picture

During the shortage, compounding pharmacies were legally permitted to produce semaglutide copies to help meet demand. While this helped many patients access treatment, it also increased regulatory and supply chain complexity. When the FDA declared the shortage resolved, all authorized compounding windows closed, a transition that has left some patients scrambling to switch to FDA-approved brand-name products.

Consequences of the Wegovy Shortage

When Wegovy was not available, several negative outcomes occurred.

Disrupted Treatment and Weight Regain

Many patients faced a difficult choice: skip doses, reduce their dose, or stop treatment entirely. Research shows that stopping Wegovy leads to weight regain over time. Interrupting a treatment plan that's working isn't just frustrating. It can undo real progress and affect long-term health outcomes.

Restarting Risks

Here's something important to know if you have to pause your medication. Restarting Wegovy at your previous dose after a long break can cause significant side effects, including nausea, headaches, and gastrointestinal discomfort. Wegovy's dose escalation schedule exists for a reason. If you have stopped and are restarting, always work with your healthcare provider to taper back to a lower dose before ramping back up.

The Compounded Semaglutide Transition

During the shortage, some patients used compounded semaglutide. A compounded drug is a medication made by a licensed pharmacy or outsourcing facility, often to meet a specific patient need or to help fill a gap during a drug shortage. Compounded drugs are not the same as FDA-approved medications.

Now that the semaglutide shortage has been resolved, many patients who used compounded semaglutide may need to discuss switching to an FDA-approved option, such as Wegovy or Ozempic, with their healthcare provider. Cost may be part of that conversation, since brand-name medications can be more expensive than compounded versions.

How to Track Wegovy Availability?

To track Wegovy availability, start with the FDA Drug Shortages Database. This can tell you whether Wegovy or another medication is in a national shortage, why the shortage is happening, and when supply may improve. You can also check the ASHP Current Drug Shortages list, which pharmacists often use to monitor supply issues.

These tools do not show real-time pharmacy shelf inventory. For local availability, call your pharmacy and ask whether your exact Wegovy dose is in stock or can be ordered. You may also ask whether another location in the same pharmacy network has your prescribed dose.

What to Do If Wegovy Is Out of Stock

Even with the national shortage resolved, you may occasionally encounter a Wegovy backordered situation at your specific pharmacy. Here's what to do.

Call Around or Ask Your Pharmacy to Do It

If your pharmacy is out of stock, don't assume every pharmacy is. Independent pharmacies, mail-order pharmacies, and different chains within your area may have inventory that your usual pharmacy doesn't. Ask your pharmacist to call sister locations, or call around yourself. It takes a little legwork, but it often pays off.

Talk to Your Provider About Dose Alternatives

How long is Wegovy on backorder at your pharmacy? If you're facing a wait, your healthcare provider may be able to help bridge the gap. They might recommend staying at a lower dose temporarily rather than missing doses entirely. Maintaining some level of treatment consistency is generally better than stopping altogether, but always make this decision with your provider.

Ask About Alternative GLP-1 Medications

If Wegovy is unavailable at every pharmacy you can reach, your provider may discuss alternative GLP-1 medications. Options like Zepbound (tirzepatide) or Saxenda (liraglutide) may be available when Wegovy is not, though dosing and side effect profiles differ between medications. These aren't one-size-fits-all substitutions, so your provider's guidance is essential.

Consider the New Oral Wegovy Pill

If you have had trouble using injectable Wegovy, the new oral Wegovy pill may be worth discussing with your healthcare provider. This may be helpful if you prefer to avoid needles, have had trouble finding injectable doses, or find refrigerated medication difficult to manage.

The once-daily tablet offers a needle-free option. Your healthcare provider can help you decide whether the pill or injection is a better fit for your treatment plan.

Use ScriptSave® WellRx to Save on Wegovy

Cost can be one of the biggest barriers to taking Wegovy. ScriptSave® WellRx may help by letting you compare prescription prices at pharmacies near you.

Some members save up to 80%* on their prescriptions. Brand-name GLP-1 medications like Wegovy can still be expensive, even with savings. However, comparing prices across pharmacies may help you find a better price. WellRx may also help you save on other medications you take along with your weight-loss treatment.

Visit wellrx.com to search prices at pharmacies near you. Prices vary by zip code, and even pharmacies across the street from each other can have significant price differences. We've been helping consumers navigate prescription costs for over 25 years, and our goal is simple: to give you the transparency you need to keep more money in your pocket.

*DISCOUNT ONLY – NOT INSURANCE. The program is administered by Medical Security Card Company, LLC.

Related FAQs

 

Is there still a Wegovy Shortage?

No. As of February 21, 2025, the FDA officially declared the semaglutide injection shortage resolved. Novo Nordisk's manufacturing expansion brought supply in line with demand. Is there still a shortage of Wegovy in your area? Localized stock gaps can still happen, but these are standard supply chain delays, not a national crisis. Check the FDA's drug shortage database for the most current status.

Is Wegovy on backorder?

No. The FDA-declared shortage is over, and Novo Nordisk has built up significant inventory reserves. That said, individual pharmacies may occasionally show a Wegovy manufacturer backorder status for specific doses as products move through the supply chain. If your pharmacy is out of stock, try calling other locations or checking mail-order options before assuming there's a broader problem.

Is Wegovy available now?

Yes, for most patients in most areas, Wegovy is available at pharmacies today. All injectable dose strengths are shipping to distributors nationwide. Wegovy in pill form is also a new option as of January 2026. The once-daily oral Wegovy tablet gives patients who prefer not to inject a brand-new path to treatment. Check with your pharmacist or use an online pharmacy tool to confirm your specific dose is in stock locally.

Is Wegovy hard to get?

Much less so than it was during the shortage years. The days of pharmacy-hopping and waiting weeks for a backorder to clear are largely over. The main challenge for many patients now is cost, not supply. With brand-name Wegovy sometimes running over $1,000 per month at list price without insurance, affordability remains the real barrier. Using a prescription savings program like ScriptSave WellRx and checking if you qualify for Novo Nordisk's savings card can help.

Which doses of Wegovy were affected by the shortage in 2022-25?

All five injectable doses, 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, experienced shortages at various points between 2022 and early 2025. The severity and timing differed by dose, depending on how many patients were in the dose escalation phase versus the maintenance phase at any given time. Starter doses were frequently the most scarce, since the rapid surge of new patients all required the lower initiation doses simultaneously.

Where to buy Wegovy online?

Wegovy requires a valid prescription from a licensed healthcare provider, regardless of where you purchase it. Many telehealth platforms, including those affiliated with licensed prescribers, can help you obtain a prescription and connect you with a pharmacy that ships Wegovy directly to your door. Always make sure the pharmacy is licensed and that a valid prescription is required. If you're managing costs, use ScriptSave WellRx at wellrx.com to compare prices and find the best deal near you before you fill your prescription.

Author Bio

Alyse Thompson, M.D., is a freelance medical writer with experience caring for patients in primary and urgent care settings. She also has a master's degree in basic medical science. She has managed acute and chronic diseases and participated in medical and pharmaceutical research.

References

https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st=c

https://www.novonordisk-us.com/supply-update.html

https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916472

https://www.pharmacytimes.com/view/fda-ends-semaglutide-shortage-listing-contributing-to-ongoing-legal-challenges

https://www.ajmc.com/view/fda-approves-oral-semaglutide-as-first-glp-1-pill-for-weight-loss

https://abcnews.go.com/GMA/Wellness/fda-approves-wegovy-pill-weight-loss/story?id=128644712

https://www.drugtopics.com/view/fda-declares-shortage-of-ozempic-wegovy-resolved